Zhili Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zhili Li has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Meixiong Cheng
Department of Neurosurgery, School of Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
3 shared publicationsLing Liu
Department of Neurosurgery, School of Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
2 shared publicationsMin Xu
Department of Neurosurgery Critical Care Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, P.R. China
2 shared publicationsTian Zhang
Department of Neurosurgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, P.R. China
2 shared publications- Yaqiu Wu
Department of Neurosurgery Intensive Care Unit, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, PR China
2 shared publications Yi Zeng
Department of Neurosurgery Critical Care Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, P.R. China
2 shared publications
Latest Publications
- 7 September 2023
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (2) , 1044-1060
Deferoxamine Mitigates Ferroptosis and Inflammation in Hippocampal Neurons After Subarachnoid Hemorrhage by Activating the Nrf2/TXNRD1 Axis
Ferroptosis is a distinct peroxidation-driven form of cell death tightly involved in subarachnoid hemorrhage (SAH). This study delved into the mechanism of deferoxamine (DFO, an iron chelator) in SAH-induced ferroptosis and inflammation. SAH mouse models were established by endovascular perforation method and injected intraperitoneally with DFO, or intraventricularly injected with the Nrf2 pathway inhibitor ML385 before SAH, followed by detection of neurological function, blood–brain barrier (BBB) permeability, and brain water content. Apoptotic level of hippocampal neurons, symbolic changes of ferroptosis, and levels of pro-inflammatory cytokines were assessed using TUNEL staining, Western blotting, colorimetry, and ELISA. The localization and expression of nuclear factor-erythroid 2-related factor 2 (Nrf2) were detected. HT22 cells were exposed to Hemin as in vitro SAH models and treated with FIN56 to induce ferroptosis, followed by evaluation of the effects of DFO on FIN56-treated HT22 cells. The regulation of Nrf2 in thioredoxin reductase 1 (TXNRD1) was analyzed by co-immunoprecipitation and Western blotting. Moreover, HT22 cells were treated with DFO and ML385 to identify the role of DFO in the Nrf2/TXNRD1 axis. DFO extenuated brain injury, and ferroptosis and inflammation in hippocampal neurons of SAH mice. Nrf2 localized at the CA1 region of hippocampal neurons, and DFO stimulated nuclear translocation of Nrf2 protein in hippocampal neurons of SAH mice. Additionally, DFO inhibited ferroptosis and inflammatory responses in FIN56-induced HT22 cells. Nrf2 positively regulated TXNRD1 protein expression. Indeed, DFO alleviated FIN56-induced ferroptosis and inflammation via activation of the Nrf2/TXNRD1 axis. DFO alleviated neurological deficits, BBB disruption, brain edema, and brain injury in mice after SAH by inhibiting hippocampal neuron ferroptosis via the Nrf2/TXNRD1 axis. DFO ameliorates SAH-induced ferroptosis and inflammatory responses in hippocampal neurons by activating the Nrf2/TXNRD1 axis.
- 7 September 2023
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (2) , 1044-1060
Deferoxamine Mitigates Ferroptosis and Inflammation in Hippocampal Neurons After Subarachnoid Hemorrhage by Activating the Nrf2/TXNRD1 Axis
Ferroptosis is a distinct peroxidation-driven form of cell death tightly involved in subarachnoid hemorrhage (SAH). This study delved into the mechanism of deferoxamine (DFO, an iron chelator) in SAH-induced ferroptosis and inflammation. SAH mouse models were established by endovascular perforation method and injected intraperitoneally with DFO, or intraventricularly injected with the Nrf2 pathway inhibitor ML385 before SAH, followed by detection of neurological function, blood–brain barrier (BBB) permeability, and brain water content. Apoptotic level of hippocampal neurons, symbolic changes of ferroptosis, and levels of pro-inflammatory cytokines were assessed using TUNEL staining, Western blotting, colorimetry, and ELISA. The localization and expression of nuclear factor-erythroid 2-related factor 2 (Nrf2) were detected. HT22 cells were exposed to Hemin as in vitro SAH models and treated with FIN56 to induce ferroptosis, followed by evaluation of the effects of DFO on FIN56-treated HT22 cells. The regulation of Nrf2 in thioredoxin reductase 1 (TXNRD1) was analyzed by co-immunoprecipitation and Western blotting. Moreover, HT22 cells were treated with DFO and ML385 to identify the role of DFO in the Nrf2/TXNRD1 axis. DFO extenuated brain injury, and ferroptosis and inflammation in hippocampal neurons of SAH mice. Nrf2 localized at the CA1 region of hippocampal neurons, and DFO stimulated nuclear translocation of Nrf2 protein in hippocampal neurons of SAH mice. Additionally, DFO inhibited ferroptosis and inflammatory responses in FIN56-induced HT22 cells. Nrf2 positively regulated TXNRD1 protein expression. Indeed, DFO alleviated FIN56-induced ferroptosis and inflammation via activation of the Nrf2/TXNRD1 axis. DFO alleviated neurological deficits, BBB disruption, brain edema, and brain injury in mice after SAH by inhibiting hippocampal neuron ferroptosis via the Nrf2/TXNRD1 axis. DFO ameliorates SAH-induced ferroptosis and inflammatory responses in hippocampal neurons by activating the Nrf2/TXNRD1 axis.
- Open Access
- 1 March 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 23, 418-430
Transcription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma
- 1 March 2021
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 23, 418-430
Open AccessTranscription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma
- Open Access
- 20 April 2020
- Published by Springer Nature in Research Square
ELF1 upregulates MEIS1 to accelerate proliferation, migration and invasion of glioma cells through the GFI1/FBW7 axis
Background: To explore whether the transcription factor ELF1 affects the GFI1-FBW7 through MEIS1, thus participating in the occurrence and development of glioma. In this study, key transcription factors were identified by differential analysis of GEO database, and downstream regulatory pathways were predicted by available literature.Methods and results: Based on bioinformatics analysis and existing studies, we speculate that the transcription factor ELF1 may regulate FBW7 through MEIS1-mediated GFI1 and thus affect the occurrence of glioma. The expressions of transcription factors ELF1, MEIS1 and GFI1 were up-regulated in glioma tissues, and the prognosis of glioma patients with high expression of ELF1 was worse.We found that interfering with ELF1 expression in glioma cells can reduce the proliferation, migration and invasion of tumor cells and induce cell apoptosis. The results of Western-blot showed that the expressions of PCNA and MMP9 were decreased, while the expression of cleaved caspase-3 was up-regulated. ChIP experiments showed that ELF1 binds to the MEIS1 promoter region, and MEIS1 can activate the enhancer of GFI1. In vivo experiments were carried out in nude mice, the results showed that interfering ELF1 could inhibit tumor growth in nude mice through the MEIS1-GFI1/FBW7.Conclusion: Therefore, interference of ELF1 in glioma can reduce its ability to recruit the transcription factor MEIS1, and further impair the activation ability of MEIS1 to GFI1 enhancer, which resulting in suppression of proliferation, migration and invasion and induction of cell apoptosis in glioma cells.
- 20 April 2020
- Published by Springer Nature in Research Square
Open AccessELF1 upregulates MEIS1 to accelerate proliferation, migration and invasion of glioma cells through the GFI1/FBW7 axis
Background: To explore whether the transcription factor ELF1 affects the GFI1-FBW7 through MEIS1, thus participating in the occurrence and development of glioma. In this study, key transcription factors were identified by differential analysis of GEO database, and downstream regulatory pathways were predicted by available literature.Methods and results: Based on bioinformatics analysis and existing studies, we speculate that the transcription factor ELF1 may regulate FBW7 through MEIS1-mediated GFI1 and thus affect the occurrence of glioma. The expressions of transcription factors ELF1, MEIS1 and GFI1 were up-regulated in glioma tissues, and the prognosis of glioma patients with high expression of ELF1 was worse.We found that interfering with ELF1 expression in glioma cells can reduce the proliferation, migration and invasion of tumor cells and induce cell apoptosis. The results of Western-blot showed that the expressions of PCNA and MMP9 were decreased, while the expression of cleaved caspase-3 was up-regulated. ChIP experiments showed that ELF1 binds to the MEIS1 promoter region, and MEIS1 can activate the enhancer of GFI1. In vivo experiments were carried out in nude mice, the results showed that interfering ELF1 could inhibit tumor growth in nude mice through the MEIS1-GFI1/FBW7.Conclusion: Therefore, interference of ELF1 in glioma can reduce its ability to recruit the transcription factor MEIS1, and further impair the activation ability of MEIS1 to GFI1 enhancer, which resulting in suppression of proliferation, migration and invasion and induction of cell apoptosis in glioma cells.
- 1 April 2017
- Published by Elsevier in World Neurosurgery
- Vol. 100, 15-21
Global Gene Expression Patterns and Somatic Mutations in Sporadic Intracranial Aneurysms
- 1 April 2017
- Published by Elsevier in World Neurosurgery
- Vol. 100, 15-21
Global Gene Expression Patterns and Somatic Mutations in Sporadic Intracranial Aneurysms